USA stockpiling of remdesivir: How should the world respond?

USA stockpiling of remdesivir: How should the world respond?

Dalia Dawoud, Kalipso Chalkidou, Richard Sullivan, Francis J Ruiz, Amanda Adler

The race to find an effective treatment for coronavirus disease 2019 (COVID-19) is still on, with only two treatment options currently authorized for emergency use and/or recommended for patients hospitalized with severe respiratory symptoms: low-dose dexamethasone and remdesivir. The USA decision to stockpile the latter has resulted in widespread condemnation and in similar action being taken by some other countries. In this commentary we discuss whether stockpiling remdesivir is justified in light of the currently available evidence.

2020

coronavirus, antiviral, covid-19, SARS-CoV-2, Remdesivir, Dexamethasone, stockpiling

10.2217/cer-2020-0174

Journal of comparative effectiveness research